Ayati is developing NEUMU (Neuropathy Measurement Unit) to screen neuropathic patients (who are having no or minimal sensation) among diabetic patients at an early stage to prevent foot amputations which may range from toe to entire leg.

Momentum is derived from funding recency, velocity, round count and scale.

Ayati Foot Labs brings together clinically relevant, point-of-care technologies for comprehensive assessment of neuropathy, vascular status, microcirculation,

Manufacture of machinery and equipment n.e.c.

Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.

Extracted from Ayati Devices Private Limited's own website, fetched Jul 2026. Verification badges reflect format/MX checks, not endorsement.